Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia by Mohammed Alqahtani, Ahmed Al-jedai, Albert Wertheimer

Subjects: “…Biosimilars…”
Get full text

Biologics in ocular inflammatory diseases – Experience from a tertiary referral eye care center in South India by Kalpana Babu, PG Padmapriya, Anand P Rao, Ramesh Jois

Subjects: Get full text

A Cost-Effective and Robust Cell-Based Bioassay Method for Evaluating the Bioactivity of Trastuzumab-like Antibodies by Pooja Bharali, Subhash Chand, Harish Chander

Subjects: Get full text

Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria by Rufai A. Dachi, Mustapha S. Umar, Maryam Mahdi, Nura H. Alkali, Falmata G. Mustapha, Fatima M. Muhammad, Alhaji Abdu

Subjects: Get full text

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography by Hesham M. El Mazar, El sayed E. El Shayeb, Asmaa M. Ebrahim, Ayatullah S.A. Motawe, Esraa S. El-Ghoubashy

Subjects: Get full text

Ulcerative colitis: STRIDE-ing beyond symptoms with new standards by Shu Wen Tay, Kevin Kim Jun Teh, Tiing-Leong Ang, Malcolm Tan

Subjects: Get full text

Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG study by Debdulal Chakraborty, Tushar Kanti Sinha, Soumen Mondal, Subhendu Boral, Arnab Das, Saptorshi Majumbar, Angshuman Mukherjee, Ranabir Bhattacharya, Sumit Randhir Singh

Subjects: Get full text

Safety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis by Arun Hegde, Vivek Vasdev, Krishnan Shanmuganandan, Kavita Singh, Sivasami Kartik, Abhishek Kumar

Subjects: “…Biosimilar…”
Get full text

A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India by Sabha Mushtaq, Devraj Dogra, Naina Dogra

Subjects: Get full text

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG? by S. V. Orlov, N. L. Shimanovskii, S. N. Fogt

Subjects: Get full text

Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India by Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee

Subjects: Get full text